Tweet
FTB Advisors Inc. grew its position in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 38.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,139 shares of the company's stock after acquiring an additional 1,438 shares during the quarter. FTB Advisors Inc.'s holdings in Express Scripts were worth $396,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently made changes to their positions in ESRX. Sumitomo Life Insurance Co. lifted its holdings in Express Scripts by 4.5% in the second quarter. Sumitomo Life Insurance Co. now owns 15,313 shares of the company's stock worth $1,182,000 after purchasing an additional 657 shares during the period. Dowling & Yahnke LLC lifted its holdings in Express Scripts by 3.0% in the 1st quarter. Dowling & Yahnke LLC now owns 24,496 shares of the company's stock valued at $1,692,000 after acquiring an additional 722 shares during the last quarter. Gibraltar Capital Management Inc. lifted its holdings in Express Scripts by 1.1% in the 2nd quarter. Gibraltar Capital Management Inc. now owns 68,278 shares of the company's stock valued at $5,272,000 after acquiring an additional 750 shares during the last quarter. Pitcairn Co. lifted its holdings in Express Scripts by 6.0% in the 1st quarter. Pitcairn Co. now owns 13,465 shares of the company's stock valued at $930,000 after acquiring an additional 761 shares during the last quarter. Finally, Hancock Holding Co. lifted its holdings in Express Scripts by 3.4% in the 1st quarter. Hancock Holding Co. now owns 23,052 shares of the company's stock valued at $1,592,000 after acquiring an additional 764 shares during the last quarter. 84.52% of the stock is owned by institutional investors. Get Express Scripts alerts:
NASDAQ ESRX opened at $87.34 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.59 and a current ratio of 0.71. The stock has a market cap of $47.02 billion, a price-to-earnings ratio of 12.30, a P/E/G ratio of 1.05 and a beta of 0.95. Express Scripts Holding Co has a 1 year low of $55.80 and a 1 year high of $87.69.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.20 by $0.02. The firm had revenue of $25.64 billion for the quarter, compared to the consensus estimate of $25.43 billion. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The business's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.73 EPS. sell-side analysts expect that Express Scripts Holding Co will post 9.07 earnings per share for the current year.
A number of equities research analysts have weighed in on the stock. Robert W. Baird downgraded shares of Express Scripts from an "outperform" rating to a "neutral" rating and set a $81.00 price target for the company. in a report on Friday, July 20th. BidaskClub raised shares of Express Scripts from a "hold" rating to a "buy" rating in a report on Wednesday, June 13th. Zacks Investment Research downgraded shares of Express Scripts from a "hold" rating to a "sell" rating in a report on Tuesday, May 1st. William Blair raised shares of Express Scripts from a "market perform" rating to an "outperform" rating in a report on Wednesday, August 1st. Finally, Leerink Swann cut their price target on shares of Express Scripts from $90.00 to $80.00 and set a "market perform" rating for the company in a report on Thursday, May 3rd. Three investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have given a buy rating to the stock. Express Scripts currently has an average rating of "Hold" and a consensus price target of $83.58.
In other Express Scripts news, insider Christine Houston sold 12,898 shares of the business's stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the sale, the insider now owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a filing with the SEC, which is available through this link . 0.79% of the stock is currently owned by insiders.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services